We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Diagnostics

Image: AI can be better at spotting heart failure than current tests (Photo courtesy of Pexels)

AI Tool Merges Patient Data with Blood Test Results to Detect Heart Failure

New research suggests that using artificial intelligence (AI) can help diagnose acute heart failure with more accuracy than just the current blood test for the heart protein NT-proBNP. More...
20 Jun 2022
Image: ELF test has been strongly recommended in 2022 AACE NAFLD guidelines (Photo courtesy of Siemens Healthineers)

Simple Blood Test Assesses Prognosis of Advanced Liver Fibrosis in NASH Patients

A non-invasive blood test that measures three direct markers of fibrosis provides a direct quantitative measure for the assessment of disease progression in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH). More...
17 Jun 2022
Image: A liquid biopsy can determine if a patient with esophageal cancer will respond to certain treatments (Photo courtesy of Pexels)

Liquid Biopsy Assay Predicts if Esophageal Cancer Patients Will Respond to Treatment

Researchers have developed a liquid biopsy that can effectively determine if a patient with esophageal cancer will respond to certain treatments. More...
17 Jun 2022
Image: Computer-generated three dimensional drawing of a chromosome mutation (Photo courtesy of 123rf.com)

Chromosome Instability Patterns Predict Tumor Drug Response

Genomic researchers characterized 17 different types of chromosomal instability, which could be used to predict tumor drug response and to aid in the identifying future drug targets. More...
16 Jun 2022
Image: Histopathological image of multiple myeloma in a bone marrow aspirate (Photo courtesy of Wikimedia Commons)

Gene Panel Predicts Likelihood of Favorable Response by Multiple Myeloma Patients to Selinexor Treatment

A novel three-gene expression signature has been identified that can be used to predict the response of multiple myeloma (MM) patients to the chemotherapeutic drug selinexor. More...
16 Jun 2022
Image: T-Detect Lyme detects early Lyme disease with greater sensitivity than antibody tests (Photo courtesy of Pexels)

T-Cell Clinical Test Shortens Time to Accurate Diagnosis of Early Lyme Disease

A simple blood test leverages the immune system’s natural abilities and the specificity of T cells to detect early Lyme disease with greater sensitivity than leading antibody tests. More...
16 Jun 2022
Image: The AllPrep DNA/RNA FFPE Kit is used for simultaneous purification of genomic DNA and total RNA from formalin-fixed, paraffin-embedded tissue sections (Photo courtesy of Qiagen)

Recurrent Disease Following DCIS Unrelated to Initial Lesions

Ductal carcinoma in situ (DCIS) is the most common form of pre-invasive breast cancer and, despite treatment, a small fraction (5% to 10%) of DCIS patients develop subsequent invasive disease. While DCIS are generally low-grade lesions that do not progress, a small portion of patients do experience recurrence, even after treatment. More...
15 Jun 2022
New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2024 Globetech Media. All rights reserved.